1. Home
  2. DCGO vs XBIT Comparison

DCGO vs XBIT Comparison

Compare DCGO & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DocGo Inc.

DCGO

DocGo Inc.

HOLD

Current Price

$0.52

Market Cap

65.5M

Sector

Health Care

ML Signal

HOLD

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.34

Market Cap

71.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCGO
XBIT
Founded
2015
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Pharmaceuticals and Biotechnology
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.5M
71.3M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
DCGO
XBIT
Price
$0.52
$2.34
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$2.38
N/A
AVG Volume (30 Days)
1.4M
46.1K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$322,196,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.52
$2.09
52 Week High
$2.45
$3.61

Technical Indicators

Market Signals
Indicator
DCGO
XBIT
Relative Strength Index (RSI) 35.07 49.72
Support Level N/A $2.24
Resistance Level $0.87 $2.69
Average True Range (ATR) 0.05 0.05
MACD -0.00 0.00
Stochastic Oscillator 2.54 53.12

Price Performance

Historical Comparison
DCGO
XBIT

About DCGO DocGo Inc.

DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.

About XBIT XBiotech Inc.

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.

Share on Social Networks: